文献速递肝病

非酒精性脂肪性肝病与亚临床冠状动脉粥样硬化之间的关联:一项观察性队列研究

Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study.
PubMed 文献 · J Hepatol · 2017-12-20

在5121例无冠状动脉疾病史的无症状体检人群中,38.6%经超声诊断为非酒精性脂肪性肝病。校正心血管危险因素后,非酒精性脂肪性肝病与钙化斑块及混合斑块无显著关联,但与任何动脉粥样硬化斑块及非钙化斑块显著相关。

要点

  • 非酒精性脂肪性肝病与任何动脉粥样硬化斑块相关(校正OR 1.18,95%CI 1.03-1.35,p=0.016)。
  • 非酒精性脂肪性肝病与非钙化斑块显著相关(校正OR 1.27,95%CI 1.08-1.48,p=0.003)。
  • 脂肪肝指数≥30及非酒精性脂肪性肝病纤维化评分≥-1.455均与非钙化斑块显著相关。

核心结论

  • 在无症状接受冠状动脉CT血管造影的人群中,非酒精性脂肪性肝病与非钙化斑块持续相关,提示心血管风险增加。

研究设计与样本

  • 观察性队列研究,共纳入5121例连续的无症状、无冠状动脉疾病史且无显著酒精摄入的个体,均自愿接受腹部超声和冠状动脉CT血管造影作为健康体检的一部分。

主要发现

  • 1979例(38.6%)经超声诊断非酒精性脂肪性肝病。
  • 校正心血管危险因素后,非酒精性脂肪性肝病对钙化斑块的校正OR为1.03(95%CI 0.89-1.20,p=0.673),对混合斑块的校正OR为1.15(95%CI 0.93-1.42,p=0.214),均无统计学显著差异。
  • 非酒精性脂肪性肝病对任何动脉粥样硬化斑块的校正OR为1.18(95%CI 1.03-1.35,p=0.016),对非钙化斑块的校正OR为1.27(95%CI 1.08-1.48,p=0.003),均显著升高。
  • 脂肪肝指数≥30与非钙化斑块显著相关(OR 1.37,95%CI 1.14-1.65,p=0.001)。
  • 非酒精性脂肪性肝病纤维化评分≥-1.455与非钙化斑块显著相关(OR 1.20,95%CI 1.08-1.42,p=0.030)。

临床怎么用

  • 作者认为,非酒精性脂肪性肝病是无症状个体非钙化斑块的独立危险因素,需要针对非酒精性脂肪性肝病进行适当的药物治疗以减少未来心脏事件。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: There are limited data on the association between non-alcoholic fatty liver disease (NAFLD) and subclinical coronary atherosclerosis. This study investigated the influence of NAFLD on subclinical coronary atherosclerosis as detected by coronary computed tomography angiography (CCTA) in an asymptomatic population. METHODS: A total of 5,121 consecutive asymptomatic individuals with no prior history of coronary artery disease or significant alcohol intake voluntarily underwent abdominal ultrasonography and CCTA as part of a general health examination. Fatty liver was assessed by ultrasonography examination. The fatty liver index and NAFLD fibrosis score were also calculated. Coronary atherosclerotic plaques on CCTA were evaluated. The association between NAFLD and subclinical coronary atherosclerosis was determined by logistic regression analysis. RESULTS: Of the study participants, 1,979 (38.6%) had ultrasonography-diagnosed NAFLD. After adjustment for cardiovascular risk factors, there were no statistically significant differences in the adjusted odds ratios of NAFLD for calcified plaque (1.03; 95% CI 0.89-1.20; p = 0.673) and mixed plaque (1.15; 95% CI 0.93-1.42; p = 0.214). However, adjusted odds ratios for any atherosclerotic plaque (1.18; 95% CI 1.03-1.35; p = 0.016) and non-calcified plaque (1.27; 95% CI 1.08-1.48; p = 0.003) were significantly higher in NAFLD. In addition, there was a significant association of fatty liver index ≥30 with non-calcified plaque (1.37; 95% CI 1.14-1.65; p = 0.001) and NAFLD fibrosis score ≥-1.455 with non-calcified plaque (1.20; 95% CI 1.08-1.42; p = 0.030). CONCLUSIONS: In this large cross-sectional study of asymptomatic individuals undergoing CCTA, NAFLD was consistently associated with non-calcified plaque, suggesting an increased cardiovascular risk. LAY SUMMARY: In asymptomatic individuals, non-alcoholic fatty liver disease (NAFLD) was an independent risk factor for non-calcified plaque, which has been known as a vulnerable plaque associated with sudden and unexpected cardiac events. Therefore, appropriate medical therapy for NAFLD was required to reduce future cardiac events.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Lee SB, Park GM, Lee JY, et al. Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study. J Hepatol. 2017. PMID: 29274406. doi:10.1016/j.jhep.2017.12.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。